The global CBD nutraceuticals market size is expected to reach USD 23.17 billion by 2030, registering a CAGR of 14.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.
CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.
Based on the distribution channel, retail store segment dominated the market in 2023, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.
Request a free sample copy or view report summary: CBD Nutraceuticals Market Report
CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. The ability of the product to provide effective solutions for health problems, such as assistance in treatments of chronic pain, depression, and substance use disorders, the capacity to alleviate specific cancer symptoms, and ease of availability, contribute to this segment's growth.
The edibles and fortified foods segment accounted for the largest revenue share in 2023. The growth is attributed to advancements in formulations of CBD foods and growing awareness among consumers about its health benefits.
Retail stores segment dominated the global market in 2023. Ease of accessibility, availability of multiple alternatives, and preference by key companies in order to accomplish enhanced brand visibility have contributed to the growth of retail store segment.
North America CBD nutraceuticals market dominated the global industry with a revenue share of 54.5% in 2023. This market is primarily driven by rising consumer awareness, increased adoption of CBD in various applications, and positive regulatory scenarios in countries such as the U.S. and Canada.
Grand View Research has segmented the global CBD nutraceuticals market on the basis of on product, application, distribution channel and region:
CBD Nutraceuticals Product Outlook (Revenue, USD Million, 2018 - 2030)
CBD Tinctures
Capsules & Softgels
CBD Gummies
Others
CBD Nutraceuticals Application Outlook (Revenue, USD Million, 2018 - 2030)
Edibles And Fortified Foods
Workout Supplements
Wellness
Others
CBD Nutraceuticals Distribution Chanel Outlook (Revenue, USD Million, 2018 - 2030)
Retail Stores
Online
Pharmacies
CBD Nutraceuticals Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the CBD Nutraceuticals Market
Charlotte's Web, Inc.
Elixinol
Medical Marijuana, Inc.
CV Sciences, Inc.
Irwin Naturals
Diamond CBD.
Foria Wellness
Medterra CBD
Green Roads
Isodiol International Inc
"The quality of research they have done for us has been excellent..."